GlassScriptPhysician profile
Timothy K Colgan
NPI 1730186610
$9,117.00
in general payments reported to CMS, 2019-2025
24 companies · $1,095 in 2025
The $1,095 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $45.00 · 2021: $776 · 2022: $838 · 2023: $3,634 · 2024: $2,729 · 2025: $1,095.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,954 · Travel and Lodging: $2,487 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,953.56 |
| Travel and Lodging | $2,486.77 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,756.74 | 2020-2025 | Watchman Access System, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $1,729.11 | 2021-2025 | Micra, Corevalve Evolut R |
| Abbott Laboratories | $1,141.69 | 2021-2025 | Cardiomems, Aveir, Mitraclip |
| Merck Sharp & Dohme LLC | $578.79 | 2021-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $501.95 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $359.20 | 2021-2024 | Xarelto |
| Pfizer INC. | $295.77 | 2021-2025 | |
| Lantheus Medical Imaging, INC. | $234.24 | 2023-2024 | Definity |
| Abiomed | $222.92 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $218.69 | 2021-2025 | Eliquis |
| Amgen INC. | $198.40 | 2021-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $173.46 | 2020-2025 | Lifevest |
| Edwards Lifesciences Corporation | $138.95 | 2024-2025 | Sapien 3 Ultra Resilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.69 | 2022-2024 | Jardiance |
| Amarin Pharma, INC. | $99.89 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $89.09 | 2025 | Assure Wcd |
| Cleerly, INC. | $74.17 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Preventice Services, LLC | $50.61 | 2021 | |
| Esperion Therapeutics, INC. | $34.75 | 2021-2022 | |
| Shockwave Medical, INC | $24.43 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $20.06 | 2023 | Inpefa |
| Bard Peripheral Vascular, INC. | $17.91 | 2024 | Venovo |
| Bayer Healthcare Pharmaceuticals INC. | $17.61 | 2023 | |
| Arbor Pharmaceuticals, INC. | $15.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Colgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.